JUNE 24 - 26, 2021 / WORLDWIDE
Schema Therapy was originally conceived as a treatment for disorders that were more chronic than symptom-based conditions. Persistent depression has been distinguished from major depressive disorder based on differential etiological factors that can also predict treatment outcome. In this talk, these factors will be reviewed. Strategies used in Schema Therapy will be examined to the extent that they target these crucial mechanisms. In addition, Schema Therapy will be compared to other evidence-based treatments for persistent depression (RO-DBT & CBASP) and the practice similarities and differences will be highlighted. This review will then lead to a focus on what clinical interventions Schema Therapists might best focus on.
About the Presenter
Associate Professor Christopher Lee works in private practice and has an adjunct appointment at the University of Western Australia. He is a certified trainer by both the international society of schema therapists and the EMDR international association.
Chris conducts therapist training workshops on personality disorders and trauma treatments throughout Australia and overseas. He has published research on the assessment of schemas and the effectiveness of schema therapy for BPD and PTSD.
Chris has received an International Society for Traumatic Stress Studies and EMDRIA awards for research excellence in 1999 and 2014. In 2009, he also received the Inaugural Francine Shapiro award for research excellence conferred by the European EMDRIA.
Chris was the 2011 recipient of the Australian Psychological Society’s Ian Campbell memorial award for contributions as a scientist-practitioner to Clinical Psychology in Australia. He is currently a principal investigator in an international multi-centered randomized controlled trial on complex PTSD.
CANCELLATION POLICY: No cancellation is possible once registered. Access to all sessions will be available after the summit ends to registered participants. For questions, please contact the ISST Office at: OFFICE
Are you an ISST Member? Enjoy deep discounts on tickets for the 2021 ISST Virtual Summit.
New York, USA
©2021 International Society of Schema Therapy e.V.
International Society of Schema Therapy e.V. is a not-for-profit organization. Glossop-Ring 35, DE-61118 Bad Vilbel, Germany
Why Schema Therapy?
Schema therapy has been extensively researched to effectively treat a wide variety of typically treatment resistant conditions, including Borderline Personality Disorder and Narcissistic Personality Disorder. Read our summary of the latest research comparing the dramatic results of schema therapy compared to other standard models of psychotherapy.